Monoclonal antibodies have become the fastest-growing class of therapeutics on the market,  but it is still challenging to develop them for therapeutic applications. From the perspective of preparation development, this article reviews the research strategy of early druggability of monoclonal antibody drugs by sequence analysis and high-throughput experimental evaluation, aiming to provide reference for screening and identifying candidate therapeutic monoclonal antibody drugs that are easy to produce and stable.